Top Posts
PharmaTher (OTCQB:PHRRF) Expands PharmaPatch™ Platform into GLP-1 Obesity...
MindWalk (Nasdaq:HYFT) Announces Discovery of Antibodies Targeting TDP-43...
Alto Neuroscience (NYSE:ANRO) Receives U.S. Patent for ALTO-207...
NRx Pharmaceuticals (Nasdaq:NRXP) Seeks Accelerated Approval for NRX-100...
Aurora Cannabis (NASDAQ:ACB) Advances Powdery Mildew Resistance Research
C4 Therapeutics (Nasdaq:CCCC) Provides Update on Cemsidomide Clinical...

Breaking News

BreakingNew Product
PharmaTher (OTCQB:PHRRF) Expands PharmaPatch™ Platform into GLP-1 Obesity Therapies
BreakingR&D - Therapy
MindWalk (Nasdaq:HYFT) Announces Discovery of Antibodies Targeting TDP-43 for Neurodegenerative Diseases
BreakingNew Product
Alto Neuroscience (NYSE:ANRO) Receives U.S. Patent for ALTO-207 Depression Treatment
BreakingNew Product
NRx Pharmaceuticals (Nasdaq:NRXP) Seeks Accelerated Approval for NRX-100 Based on Real-World Evidence
BreakingR&D - Therapy
Aurora Cannabis (NASDAQ:ACB) Advances Powdery Mildew Resistance Research
BreakingR&D - Therapy
RetinalGenix (OTCQB:RTGN) Announces Retinal Thinning Study Findings
BreakingFinancings
BriaCell (Nasdaq:BCTX) Announces Pricing of $30 Million Public Offering
BreakingFinancings
Foghorn Therapeutics (Nasdaq:FHTX) Closes $50 Million Registered Direct Financing
BreakingR&D - Therapy
ImmunityBio Announces Positive ANKTIVA Clinical Program Results in Lung Cancer (NASDAQ:IBRX)
BreakingFinancings
Pelthos Therapeutics (NYSE American:PTHS) Secures $30 Million Financing from Horizon Technology Finance
Breaking
NanoViricides (NYSE American:NNVC) Highlights Need for Broad-Spectrum Antivirals Amidst Severe Flu Season
BreakingR&D - Therapy
Natera (NASDAQ:NTRA) Announces Advancement in MRD-Based Risk Stratification

More Breaking News…

Biotech Tues

Our Lead Story

Market News

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.